Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.

Authors :: Lopes, Renato D.
Elliott, Laine E.
White, Harvey D.
Hochman, Judith S.
Van de Werf, Frans
Ardissino, Diego
Nielsen, Torsten T.
Weaver, W. Douglas
Widimsky, Petr
Armstrong, Paul W.
Granger, Christopher B.
Source :: European Heart Journal; Aug2009, Vol. 30 Issue 16, p2019-2028, 10p
Publication Year :: 2009
Abstract: Aims: To assess the incidence and timing of atrial fibrillation (AF), describe antithrombotic therapy use, and evaluate the association of AF with 90 day mortality and other secondary clinical outcomes. [ABSTRACT FROM PUBLISHER]

Full Text Access

Tools